Provention Bio, Inc.
PRVB · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $789,822 | $374,036 | $258,864 | $464,088 |
| - Cash | $44,039 | $102,382 | $57,883 | $74,910 |
| + Debt | $23,910 | $23,778 | $518 | $555 |
| Enterprise Value | $769,693 | $295,432 | $201,499 | $389,733 |
| Revenue | $10,813 | $756 | $746 | $580 |
| % Growth | 1,330.3% | 1.3% | 28.6% | – |
| Gross Profit | $10,301 | $756 | $746 | $580 |
| % Margin | 95.3% | 100% | 100% | 100% |
| EBITDA | -$38,020 | -$28,234 | -$29,405 | -$28,944 |
| % Margin | -351.6% | -3,734.7% | -3,941.7% | -4,990.3% |
| Net Income | -$33,277 | -$28,188 | -$29,541 | -$21,968 |
| % Margin | -307.7% | -3,728.6% | -3,959.9% | -3,787.6% |
| EPS Diluted | -0.45 | -0.34 | -0.46 | -0.35 |
| % Growth | -32.4% | 26.1% | -31.4% | – |
| Operating Cash Flow | -$7,975 | -$23,967 | -$28,436 | -$15,030 |
| Capital Expenditures | -$373 | -$196 | -$226 | $0 |
| Free Cash Flow | -$8,348 | -$24,163 | -$28,662 | -$15,030 |